Marcello Moccia

Dr. Marcello Moccia

Federico II University offre Naples, Italy, and University College London, United Kingdom
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RERoberto Erro
Roberto Erro
CVCarmine Vitale
Carmine Vitale
MAMarianna Amboni
Marianna Amboni
Marina PicilloMarina Picillo
Marina Picillo
Marcello MocciaMarcello Moccia
Marcello Moccia
PBPaolo Barone
Paolo Barone
The variability in the clinical phenotype of Parkinson’s disease seems to suggest the existence of several subtypes of the disease. To test this hypothesis we performed a cluster analysis using data assessing both motor and non-motor symptoms in a large cohort of newly diagnosed untreated PD patients. We collected data on demographic, motor, and the whole complex of non-motor symptoms from 100 consecutive newly diagnosed untreated outpatients. Statistical cluster analysis allowed the identification of different subgroups, which have been subsequently explored. The data driven approach identified four distinct groups of patients, we have labeled: 1) Benign Pure Motor; 2) Benign mixed Motor-Non-Motor; 3) Non-Motor Dominant; and 4) Motor Dominant. Our results confirmed the existence of different subgroups of early PD patients. Cluster analysis revealed the presence of distinct subtypes of patients profiled according to the relevance of both motor and non-motor symptoms. Identification of such subtypes may have important implications for generating pathogenetic hypotheses and therapeutic strategies.

12 January 2018 in Nature Reviews Neurology
Verified
Journal Article
Closed access
PDF file
CTCarmen Tur
Carmen Tur
Marcello MocciaMarcello Moccia
Marcello Moccia
FBFrederik Barkhof
Frederik Barkhof
JCJeremy Chataway
Jeremy Chataway
JSJaume Sastre-Garriga
Jaume Sastre-Garriga
OCOlga Ciccarelli
Olga Ciccarelli

11 September 2015 in Multiple Sclerosis Journal
Verified
Journal Article
Closed access
Marcello MocciaMarcello Moccia
Marcello Moccia
RLRoberta Lanzillo
Roberta Lanzillo
RPRaffaele Palladino
Raffaele Palladino
KCKiara Chang
Kiara Chang
TCTeresa Costabile
Teresa Costabile
VMVincenzo Brescia Morra
Vincenzo Brescia Morra
Cognitive impairment occurs from the early phases of multiple sclerosis (MS), and more frequently affects secondary progressive (SP) subjects than relapsing–remitting (RR). To investigate relationships between cognitive dysfunctions in newly diagnosed RRMS, and long-term MS-related outcomes. The present 10-year retrospective longitudinal study included 155 RRMS subjects, tested with the Rao Brief Repeatable Battery at MS diagnosis. The reaching of Expanded Disability Status Scale (EDSS) 4.0, and the SP conversion were recorded. 67 subjects (43.2%) reached EDSS 4.0, and 34 subjects (21.9%) converted to SP during a follow-up period of 10.0±1.8 years. Subjects with cognitive impairment at diagnosis had a rate of reaching EDSS 4.0 more than three times greater (p<0.001; HR=3.183), and a rate of SP conversion more than two times greater, as compared to cognitively preserved subjects (p=0.008; HR=2.535). In particular, better scores in the Selective Reminding Test-Delayed Recall and in the Symbol Digit Modalities Test at baseline were associated with lower SP conversion rates during the follow-up period (p=0.018; HR=0.835; and p=0.001; HR=0.941, respectively). Cognitive impairment, with particular involvement of processing speed and memory, predicts disability progression and SP conversion in newly diagnosed RRMS, highlighting the importance of cognitive assessment from the beginning of MS.

1 October 2015 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
GSGabriella Santangelo
Gabriella Santangelo
CVCarmine Vitale
Carmine Vitale
Marina PicilloMarina Picillo
Marina Picillo
Marcello MocciaMarcello Moccia
Marcello Moccia
SCSofia Cuoco
Sofia Cuoco
PBPaolo Barone
Paolo Barone

21 September 2017 in Multiple Sclerosis Journal
Verified
Journal Article
Closed access
RLRoberta Lanzillo
Roberta Lanzillo
GCGilda Cennamo
Gilda Cennamo
CCChiara Criscuolo
Chiara Criscuolo
ACAntonio Carotenuto
Antonio Carotenuto
NVNunzio Velotti
Nunzio Velotti
VMVincenzo Brescia Morra
Vincenzo Brescia Morra
Optical coherence tomography (OCT) angiography is a new method to assess the density of the vascular networks. Vascular abnormalities are considered involved in multiple sclerosis (MS) pathology. To assess the presence of vascular abnormalities in MS and to evaluate their correlation to disease features. A total of 50 MS patients with and without history of optic neuritis (ON) and 46 healthy subjects were included. All underwent spectral domain (SD)-OCT and OCT angiography. Clinical history, Expanded Disability Status Scale (EDSS), Multiple Sclerosis Severity Score (MSSS) and disease duration were collected. Angio-OCT showed a vessel density reduction in eyes of MS patients when compared to controls. A statistically significant reduction in all SD-OCT and OCT angiography parameters was noticed both in eyes with and without ON when compared with control eyes. We found an inverse correlation between SD-OCT parameters and MSSS (p = 0.003) and between vessel density parameters and EDSS (p = 0.007). We report a vessel density reduction in retina of MS patients. We highlight the clinical correlation between vessel density and EDSS, suggesting that angio-OCT could be a good marker of disease and of disability in MS.

1 May 2015 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
GSGabriella Santangelo
Gabriella Santangelo
CVCarmine Vitale
Carmine Vitale
Marina PicilloMarina Picillo
Marina Picillo
SCSofia Cuoco
Sofia Cuoco
Marcello MocciaMarcello Moccia
Marcello Moccia
SPSabina Pappatà
Sabina Pappatà